Emergent BioSolutions EBS
NYSE EBS
$6.19 -0.10 (-1.59%)
As of: Oct 21, 2026 · 3:59 PM EDT

Emergent BioSolutions (EBS) Depreciation & Amortization (CF) (2010 - 2026)

Updated

Emergent BioSolutions (EBS) posted Depreciation & Amortization (CF) of $24 million for Q2 2026, up 2.1% from $23.5 million a year earlier and up 2.1% from the prior quarter.

Analysis

Emergent BioSolutions (EBS) Depreciation & Amortization (CF) (2010 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Depreciation & Amortization (CF) at Emergent BioSolutions was $94.4 million, down 6.8% year-over-year; for FY2025, it came in at $95.8 million, down 11.9% from FY2024.

  • Annual Depreciation & Amortization (CF) has declined for three consecutive years, with a five-year compound annual growth rate of -3.5% (FY2020 to FY2025).
  • In prior years, Emergent BioSolutions' Depreciation & Amortization (CF) was $108.8 million in FY2024 (-13.0%), $125.1 million in FY2023 (-12.7%), $143.3 million in FY2022 (+15.8%) and $123.8 million in FY2021 (+8.1%).
  • The Q2 2026 figure stands as the highest quarterly Depreciation & Amortization (CF) since Q1 2025.
  • On a year-over-year basis, Depreciation & Amortization (CF) increased in 1 of the last eight quarters, with an average decline of 8.8%.
  • The strongest year-over-year quarter for Depreciation & Amortization (CF) in the past five years was Q2 2022, with growth of 34.0%; the weakest was Q2 2023, with a decline of 26.1%.
  • According to Business Quant data, Depreciation & Amortization (CF) for the three prior quarters was $23.5 million (Q1 2026), $23.5 million (Q4 2025) and $23.4 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 534.00 Mn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 1.96 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 194.00 Mn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 599.00 Mn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 1.93 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 1.11 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 98.00 Mn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 1.62 Bn
10 Emergent BioSolutions 319.40 Mn -431.50 Mn 137.20 Mn 24.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 24.00 Mn
Mar 31, 2026 23.50 Mn
Dec 31, 2025 23.50 Mn
Sep 30, 2025 23.40 Mn
Jun 30, 2025 23.50 Mn
Mar 31, 2025 25.40 Mn
Dec 31, 2024 26.00 Mn
Sep 30, 2024 26.40 Mn
Jun 30, 2024 28.50 Mn
Mar 31, 2024 27.90 Mn
Dec 31, 2023 29.60 Mn
Sep 30, 2023 28.00 Mn
Jun 30, 2023 32.90 Mn
Mar 31, 2023 34.60 Mn
Dec 31, 2022 35.70 Mn
Sep 30, 2022 32.20 Mn
Jun 30, 2022 44.50 Mn
Mar 31, 2022 30.90 Mn
Dec 31, 2021 29.20 Mn
Sep 30, 2021 32.70 Mn
API Access

Emergent BioSolutions Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=EBS&period=max&api_key=YOUR_API_KEY